| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Yi-Hsuan Lee | |
| I-Wen Sun | |||
| Chia-Fen Tsai | |||
| Yung-Chieh Yen | |||
| I-Chao Liu | |||
| Yuan Hwa Chou | |||
| Szu-Wei Wu | |||
| Chen-Lin Chang | |||
| Chien-Liang Huang | |||
| Jen-Chin Lee | |||
| Po-Chung Chu | |||
| P2860 | cites work | Use of long-acting risperidone in the treatment of bipolar patients | Q80265676 |
| Usefulness of long-acting injectable risperidone during 12-month maintenance therapy of bipolar disorder | Q80390738 | ||
| A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder | Q80771740 | ||
| Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression | Q81247851 | ||
| Practice guideline for the treatment of patients with bipolar disorder (revision) | Q95789383 | ||
| Effects of risperidone and olanzapine dose reduction on cognitive function in stable patients with schizophrenia: an open-label, randomized, controlled, pilot study | Q37131080 | ||
| Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | Q37426143 | ||
| Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review | Q37625681 | ||
| Antipsychotic long-acting injections in clinical practice: medication management and patient choice. | Q37625693 | ||
| Risperidone long-acting injectable (Risperdal Consta®) for maintenance treatment in patients with bipolar disorder | Q37803220 | ||
| Long-acting injectable aripiprazole: how might it fit in our tool box? | Q38104208 | ||
| Taiwan consensus of pharmacological treatment for bipolar disorder | Q38128114 | ||
| Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder | Q43130555 | ||
| A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently | Q43239518 | ||
| Treatment adherence with antipsychotic medications in bipolar disorder | Q44083784 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. | Q44142664 | ||
| Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients | Q46732807 | ||
| A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder | Q48697520 | ||
| Poor adherence to treatment associated with a high recurrence in a bipolar disorder outpatient sample | Q49157018 | ||
| Treatment of bipolar disorder | Q28290437 | ||
| Current and emerging therapies for the management of bipolar disorders | Q28686902 | ||
| Long-acting risperidone: a review of its role in the treatment of bipolar disorder | Q33886093 | ||
| Excess mortality in bipolar and unipolar disorder in Sweden | Q33954560 | ||
| Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms | Q34060640 | ||
| Emerging treatments in the management of bipolar disorder - focus on risperidone long acting injection. | Q34122946 | ||
| Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder | Q34267385 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. | Q34588960 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression | Q34616633 | ||
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder | Q34649187 | ||
| Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness | Q35073474 | ||
| Medication adherence and the use of long-acting antipsychotics in bipolar disorder | Q36783862 | ||
| Risperidone long-acting injection: a review of its long term safety and efficacy | Q37062563 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 121-128 | |
| P577 | publication date | 2015-08-01 | |
| P1433 | published in | Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology | Q26842559 |
| P1476 | title | A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder | |
| P478 | volume | 13 |
| Q46305146 | A Retrospective Study of Long Acting Risperidone Use to Support Treatment Adherence in Youth with Conduct Disorder |
| Q94235375 | A Severe Case of Paliperidone Palmitate-Induced Parkinsonism Leading to Prolonged Hospitalization: Opportunities for Improvement |
| Q26766541 | A critical appraisal of paliperidone long-acting injection in the treatment of schizoaffective disorder |
| Q37643038 | Clinical Practice Guidelines for Management of Bipolar Disorder |
| Q28078078 | Efficacy and safety of second-generation antipsychotic long-acting injections (SGA LAIs) in maintenance treatment of bipolar disorder: protocol for a systematic review and meta-analysis |
| Q55364906 | Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1. |
| Q55438360 | Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2. |
| Q64246759 | Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres |
| Q38902384 | Medication Adherence in Patients with Bipolar Disorder: A Comprehensive Review. |
| Q50140700 | Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. |
| Q50708105 | Response Surface Analysis and Nonlinear Optimization Algorithm for Maximization of Clinical Drug Performance: Application to Extended-Release and Long-Acting Injectable Paliperidone. |
| Q91962622 | Risperidone-Loaded PLGA-Lipid Particles with Improved Release Kinetics: Manufacturing and Detailed Characterization by Electron Microscopy and Nano-CT |
| Q92996096 | Second-generation antipsychotic long-acting injections in bipolar disorder: Systematic review and meta-analysis |
| Q90731575 | Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment |
Search more.